Metacognitive Training for Negative Symptoms in Schizophrenia
Official title: Metacognitive Training for Negative Symptoms (MCT Minus)
Run by Sormland County Council, Sweden · NCT06127004 · Data updated 2026-11-12
This study is testing if a new training program can help people with schizophrenia feel less withdrawn and more engaged in life compared to regular counseling.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Sormland County Council, Sweden Academic / other |
| Locations | 1 site (Multiple Locations) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | December 2030 |
| Study ends | December 2032 |
| Registry record updated | February 6, 2024 |
| Trial ID | NCT06127004 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 with a clinical diagnosis of schizophrenia, delusional disorder, or non-affective psychosis residing in specific regions of Sweden.
✕Probably not a fit
Patients with severe organic brain dysfunction, learning disabilities, or those unable to communicate in Swedish may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of Metacognitive Training (MCT) Minus, specifically designed to address negative symptoms in individuals with schizophrenia and related disorders. Unlike traditional approaches that focus on positive symptoms, this intervention aims to reduce persistent negative symptoms such as social withdrawal and avolition. The study will assess the impact of MCT Minus on patients' functioning and symptomatology, providing a scientific basis for its efficacy. Participants will receive either MCT Minus or supportive counseling as part of the intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the quality of life for patients suffering from negative symptoms of schizophrenia.
How similar studies have gone: While there is limited research specifically on MCT Minus for negative symptoms, the need for effective interventions targeting these symptoms has been recognized, indicating potential for success in this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Over the age of 18 * Clinical diagnosis of schizophrenia, delusional disorder or non-affective psychosis * Resident in Region Sörmland, Region Västmanland or Region Uppland Exclusion Criteria: * Evidence of severe organic brain dysfunction * Learning disabilities * Difficulty with the Swedish language * Visual and/or hearing impairment * Being unable or unwilling to provide written informed consent
Where it's running
-
Region Sörmland
Multiple Locations, Sweden Recruiting
Study contacts
- Principal investigator: Linda Swanson, Dr — Region Sörmland/ Uppsala University
- Study coordinator: Linda Swanson, Dr
- Email: linda.swanson@regionsormland.se
- Phone: 0046-720 843 708
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using 40 Hz visual stimulation to help with negative symptoms in schizophrenia
This study is testing if 40 Hz visual stimulation can help people with schizophrenia or schizoaffective disorder feel better by reducing negative symptoms.
-
Using rTMS to treat negative symptoms of schizophrenia
This study is testing if a new type of brain treatment called rTMS can help reduce negative symptoms in people with schizophrenia.
-
Validation of Lithuanian mental health assessment scales
This study is testing new Lithuanian mental health scales to see if they accurately measure symptoms of schizophrenia in adults aged 18 to 65.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.